文献速递甲状腺疾病

老年人甲状腺功能与自身免疫的变化:Whickham队列的纵向分析

Changes in Thyroid Function and Autoimmunity in Older Individuals: Longitudinal Analysis of the Whickham Cohort.
PubMed 文献 · J Clin Endocrinol Metab · 2025-01-01

对Whickham队列204名幸存者(平均年龄77.0岁,女性56%)在2008–2012年和2016–2019年两次评估,中位随访7.8年。血清TSH升高0.29 mU/L(12.4%),FT3和TPOAb分别降低0.1 pmol/L(-2.1%)和0.6 U/L(-11.2%),FT4无显著变化。采用标准参考范围时亚临床甲状腺功能减退症患病率从基线3.5%升至随访9.0%,而采用就诊时特异性TSH参考范围后两个时间点均降至2.0%。

要点

  • 老年人随访中位7.8年间血清TSH升高0.29 mU/L(12.4%),FT3和TPOAb降低,FT4无显著变化。
  • TSH计算上限从4.74 mU/L升至6.28 mU/L,TSH与FT4关系无显著变化。
  • 采用标准参考范围亚临床甲状腺功能减退症患病率从3.5%升至9.0%,采用就诊时特异性范围则均为2.0%。

核心结论

  • 甲状腺功能随年龄增长出现细微但显著的变化,使用标准参考范围倾向于增加对老年甲状腺功能正常个体亚临床甲状腺功能减退症的诊断。
  • 作者认为采用年龄适宜的TSH参考范围可能降低诊断和(潜在不必要地)治疗亚临床甲状腺功能减退症的风险。

研究设计与样本

  • Whickham队列研究幸存者的纵向分析,于2008–2012年和2016–2019年两次评估。
  • 共纳入204人,平均年龄77.0(±6.6)岁,女性114人(56%),中位随访7.8(7.3–8.2)年。
  • 两次均使用相同检测方法在相似条件下测定血清TSH、游离T4(FT4)、游离T3(FT3)和甲状腺过氧化物酶抗体(TPOAb)。
  • 排除已知甲状腺疾病或使用影响甲状腺功能药物的个体;记录合并症,采用计时起立行走测试评估功能活动能力,握力测试评估肌肉功能。

主要发现

  • 血清TSH升高0.29 mU/L(12.4%),FT3降低0.1 pmol/L(-2.1%),TPOAb降低0.6 U/L(-11.2%),FT4无显著变化。
  • 血清TSH计算上限从4.74 mU/L升至6.28 mU/L。
  • 两个时间点血清TSH与FT4的关系无显著差异。
  • 采用标准实验室参考范围时,亚临床甲状腺功能减退症患病率从基线3.5%升至随访9.0%。
  • 采用就诊时特异性TSH参考范围后,两个时间点亚临床甲状腺功能减退症患病率均降至2.0%。

临床怎么用

  • 作者认为采用年龄适宜的TSH参考范围可能降低诊断和(潜在不必要地)治疗亚临床甲状腺功能减退症的风险。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Longitudinal studies of thyroid function have demonstrated differing results. It remains unclear whether changes in thyroid function affect the diagnosis of subclinical thyroid dysfunction with aging. METHODS: Survivors of the Whickham cohort study were evaluated on 2 occasions between the years 2008 and 2012 and 2016 and 2019. Serum TSH, free T4 (FT4), free T3 (FT3), and thyroid peroxidase antibody (TPOAb) were measured on both occasions using the same assay under similar conditions. Individuals with known thyroid disease or on medications affecting thyroid function were excluded. Comorbidities were noted, functional mobility was assessed by the timed up-and-go test, and muscle function was evaluated by the hand grip strength test. RESULTS: In 204 individuals (mean age 77.0 [±6.6] years, 114 [56%] female), followed over a median (interquartile range) of 7.8 (7.3-8.2) years, serum TSH increased by 0.29 mU/L (12.4%), FT3 and TPOAb reduced by 0.1 pmol/L (-2.1%) and 0.6 U/L (-11.2%), and there were no significant changes in FT4 levels. The calculated upper limit of serum TSH increased over the follow-up period from 4.74 mU/L to 6.28 mU/L. The relationship between serum TSH and FT4 at both time points was not significantly different. Utilizing standard laboratory reference ranges, the prevalence of subclinical hypothyroidism increased from 3.5% at baseline to 9.0% at follow-up. However, adopting a visit-specific TSH reference range reduced the prevalence of subclinical hypothyroidism at both time points to 2.0%. DISCUSSION: Thyroid function demonstrates subtle but significant changes with age. Utilizing standard reference ranges tends to increase the diagnosis of subclinical hypothyroidism in older euthyroid individuals. Our data suggest that adopting age-appropriate TSH reference ranges may reduce the risk of diagnosing and (potentially unnecessarily) treating subclinical hypothyroidism.

来源:J Clin Endocrinol Metab,查看原文。版权归原作者所有。

引用

  1. Razvi SS, Wild H, Ingoe L, et al. Changes in Thyroid Function and Autoimmunity in Older Individuals: Longitudinal Analysis of the Whickham Cohort. J Clin Endocrinol Metab. 2025. PMID: 39673773. doi:10.1210/clinem/dgae875

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。